Many businesses in the life sciences sector are considering mergers or acquisitions and collaboration arrangements to expand their portfolios of existing products. Others are looking to expand overseas into new markets. Most of these transactions are complex, multi-faceted, and create significant uncertainty regarding financial reporting. Businesses dealing with these issues require advisors with experience and insight into these arrangements and the many challenges that come with them. BDO’s teams provide guidance to pharmaceutical, biotech, and medical device manufacturers at every stage of development.